Silver Storm Mining Ltd. (SVRSF)

SpringWorks Therapeutics Income Statement

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	2.23	3.07	2.55	1.84	2.42
Operating Expenses	12.1	7.81	15.59	2.99	4.64
Operating Income	-12.1	-7.81	-15.59	-2.99	-4.64
Interest Expense	-1.35	-0.23	-	-	-
Interest & Investment Income	0.08	0.15	0.17	-	0.02
Currency Exchange Gain (Loss)	-0.6	0.09	-0.1	0.15	-0.03
Other Non Operating Income (Expenses)	0.02	0.12	-0.23	-0.04	-0.11
EBT Excluding Unusual Items	-13.95	-7.67	-15.74	-2.88	-4.76
Gain (Loss) on Sale of Investments	-	-	-0.01	-	-0.04
Other Unusual Items	-	-	-0.62	-	-
Pretax Income	-13.95	-7.67	-16.37	-2.88	-4.8
Net Income	-13.95	-7.67	-16.37	-2.88	-4.8
Net Income to Common	-13.95	-7.67	-16.37	-2.88	-4.8
Shares Outstanding (Basic)	460	308	285	211	178
Shares Outstanding (Diluted)	460	308	285	211	178
Shares Change (YoY)	49.61%	7.81%	35.33%	18.43%	32.08%
EPS (Basic)	-0.03	-0.02	-0.06	-0.01	-0.03
EPS (Diluted)	-0.03	-0.02	-0.06	-0.01	-0.03
Free Cash Flow	-8.59	-9.62	-8.96	-3.56	-4.66
Free Cash Flow Per Share	-0.02	-0.03	-0.03	-0.02	-0.03
EBITDA	-12	-7.79	-15.13	-	-
D&A For EBITDA	0.09	0.02	0.45	-	-
EBIT	-12.1	-7.81	-15.59	-2.99	-4.64
Advertising Expenses	-	-	0.53	0.19	0.2

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.